Search Results - Dranitsaris G
- Showing 1 - 5 results of 5
-
1
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis by Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective by Dranitsaris G, Yu B, King J, Kaura S, Zhang A
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Drug tendering: drug supply and shortage implications for the uptake of biosimilars by Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma by Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Yuan Y, Juarez-Garcia A, Tyas D, Pritchard C
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes by Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book